{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:41:13Z","timestamp":1788892873539,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmi.2026.02.010","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T23:36:01Z","timestamp":1771112161000},"page":"815-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the antibacterial activity of ceftazidime\/avibactam and aztreonam combinations against multidrug-resistant Stenotrophomonas maltophilia complex isolates in a hollow fibre infection model"],"prefix":"10.1016","volume":"32","author":[{"given":"Quentin","family":"Vall\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnikant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Minh","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Mojica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Khoei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Fouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"LiPuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri G.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.02.010_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2026.02.010_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00354-18","article-title":"Microbial interactions in the cystic fibrosis airway","volume":"56","author":"Granchelli","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2026.02.010_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0284185119885117","article-title":"Imaging findings of Stenotrophomonas maltophilia pneumonia: Emphasis on CT findings between immunocompromised and immunocompetent patients","volume":"61","author":"Kang","year":"2020","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cmi.2026.02.010_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13054-019-2649-5","article-title":"Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study","volume":"23","author":"Guerci","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.02.010_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2019.08.006","article-title":"Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry","volume":"19","author":"Hatziagorou","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.cmi.2026.02.010_bib6","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41467-020-15123-0","article-title":"The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia","volume":"11","author":"Gr\u00f6schel","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2026.02.010_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhin.2017.02.003","article-title":"Stenotrophomonas maltophilia healthcare-associated infections: identification of two main pathogenic genetic backgrounds","volume":"96","author":"Corlouer","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2026.02.010_bib8","doi-asserted-by":"crossref","first-page":"dlac040","DOI":"10.1093\/jacamr\/dlac040","article-title":"Clinical challenges treating Stenotrophomonas maltophilia infections: an update","volume":"4","author":"Mojica","year":"2022","journal-title":"JAC-Antimicrob Resist"},{"key":"10.1016\/j.cmi.2026.02.010_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00777-17","article-title":"Avibactam restores the susceptibility of clinical isolates of Stenotrophomonas maltophilia to aztreonam","volume":"61","author":"Mojica","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02243-16","article-title":"Can ceftazidime-avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae?","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/dkaa549","article-title":"Pragmatic options for dose optimization of ceftazidime\/avibactam with aztreonam in complex patients","volume":"76","author":"Falcone","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00077-17","article-title":"Impacts of penicillin binding protein 2 inactivation on \u03b2-lactamase expression and muropeptide profile in Stenotrophomonas maltophilia","volume":"2","author":"Huang","year":"2017","journal-title":"mSystems"},{"key":"10.1016\/j.cmi.2026.02.010_bib13","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1128\/AAC.00264-16","article-title":"Successful treatment of bloodstream infection due to metallo-\u03b2-lactamase-producing Stenotrophomonas maltophilia in a renal transplant patient","volume":"60","author":"Mojica","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/mdr.2021.0389","article-title":"In vitro comparison of aztreonam\/amoxicillin-clavulanate versus aztreonam\/ceftazidime-avibactam on ceftazidime-avibactam resistant Stenotrophomonas maltophilia","volume":"28","author":"Cr\u00e9met","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2026.02.010_bib15","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement M100-S25","year":"2015"},{"key":"10.1016\/j.cmi.2026.02.010_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2016.10.025","article-title":"Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes","volume":"49","author":"Sharma","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2026.02.010_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/AAC.39.1.28","article-title":"Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients","volume":"39","author":"Chin","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib18","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/AAC.01522-06","article-title":"Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation","volume":"51","author":"Vinks","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01815-17","article-title":"Evaluation of activity and emergence of resistance of polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-producing Klebsiella pneumoniae","volume":"62","author":"Diep","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106924","article-title":"In vitro model to simulate multiple drugs with distinct elimination half-lives","volume":"62","author":"Hudson","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2026.02.010_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00119-16","article-title":"Transcriptomic analysis of the activity of a novel polymyxin against Staphylococcus aureus","volume":"1","author":"Zhao","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2026.02.010_bib22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a Worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections","volume":"54","author":"Farrell","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/dkv456","article-title":"Monotherapy with minocycline or trimethoprim\/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"71","author":"Hand","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib25","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/jac\/dkaa197","article-title":"Determining the optimal dosing of a novel combination regimen of ceftazidime\/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model","volume":"75","author":"Lodise","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.02.010_bib26","first-page":"1","article-title":"Synergistic efficacy of ceftazidime\/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa: insights from the hollow-fiber infection model","volume":"0","author":"Montero","year":"2024","journal-title":"Infect Dis"},{"key":"10.1016\/j.cmi.2026.02.010_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1047109","article-title":"Resistance to aztreonam-avibactam due to CTX-M-15 in the presence of penicillin-binding protein 3 with extra amino acids in Escherichia coli","volume":"13","author":"Ma","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2026.02.010_bib28","doi-asserted-by":"crossref","first-page":"e00405","DOI":"10.1128\/mBio.00405-19","article-title":"Population structure, molecular epidemiology, and \u03b2-lactamase diversity among Stenotrophomonas maltophilia Isolates in the United States","volume":"10","author":"Mojica","year":"2019","journal-title":"mBio"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:54:39Z","timestamp":1776095679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1198743X26000686"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the antibacterial activity of ceftazidime\/avibactam and aztreonam combinations against multidrug-resistant Stenotrophomonas maltophilia complex isolates in a hollow fibre infection model","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}